Cancer Vaccine Market (2026 - 2033) Size, Share & Trends Analysis Report By Vaccine Type (Preventive Cancer Vaccine, Therapeutic Cancer Vaccine), By Indication Type, By Technology Type, By Region, And Segment Forecasts

Market Segmentation

• Cancer Vaccine Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Preventive Cancer Vaccine
  • Therapeutic Cancer Vaccine
  • Others
• Cancer Vaccine Indication Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Prostate Cancer
  • Bladder Cancer
  • Melanoma
  • Combination Therapies
• Cancer Vaccine Technology Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Recombinant Cancer Vaccine
  • Whole-cell Cancer Vaccine
  • Viral Vector and DNA Cancer Vaccine
  • Others
• Cancer Vaccine Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • North America Cancer Vaccine Market, by Vaccine Type
      • Preventive Cancer Vaccine
      • Therapeutic Cancer Vaccine
      • Others
    • North America Cancer Vaccine Market, by Indication Type
      • Prostate Cancer
      • Bladder Cancer
      • Melanoma
      • Cervical Cancer
      • Other
    • North America Cancer Vaccine Market, by Technology Type
      • Recombinant Cancer Vaccine
      • Whole-cell Cancer Vaccine
      • Viral Vector and DNA Cancer Vaccine
      • Other Technologies
    • U.S.
      • U.S. Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • U.S. Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • U.S. Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Canada
      • Canada Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Canada Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Canada Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Mexico
      • Mexico Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Mexico Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Mexico Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
  • Europe
    • Europe Cancer Vaccine Market, by Vaccine Type
      • Preventive Cancer Vaccine
      • Therapeutic Cancer Vaccine
      • Others
    • Europe Cancer Vaccine Market, by Indication Type
      • Prostate Cancer
      • Bladder Cancer
      • Melanoma
      • Cervical Cancer
      • Other
    • Europe Cancer Vaccine Market, by Technology Type
      • Recombinant Cancer Vaccine
      • Whole-cell Cancer Vaccine
      • Viral Vector and DNA Cancer Vaccine
      • Other Technologies
    • UK
      • UK Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • UK Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • UK Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Germany
      • Germany Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Germany Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Germany Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • France
      • France Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • France Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • France Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Italy
      • Italy Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Italy Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Italy Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Spain
      • Spain Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Spain Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Spain Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Denmark
      • Denmark Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Denmark Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Denmark Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Sweden
      • Sweden Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Sweden Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Sweden Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Norway
      • Norway Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Norway Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Norway Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
  • Asia Pacific
    • Asia Pacific Cancer Vaccine Market, by Vaccine Type
      • Preventive Cancer Vaccine
      • Therapeutic Cancer Vaccine
      • Others
    • Asia Pacific Cancer Vaccine Market, by Indication Type
      • Prostate Cancer
      • Bladder Cancer
      • Melanoma
      • Cervical Cancer
      • Other
    • Asia Pacific Cancer Vaccine Market, by Technology Type
      • Recombinant Cancer Vaccine
      • Whole-cell Cancer Vaccine
      • Viral Vector and DNA Cancer Vaccine
      • Other Technologies
    • China
      • China Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • China Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • China Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Japan
      • Japan Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Japan Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Japan Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • India
      • India Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • India Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • India Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Australia
      • Australia Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Australia Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Australia Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • South Korea
      • South Korea Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • South Korea Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • South Korea Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Thailand
      • Thailand Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Thailand Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Thailand Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
  • Latin America
    • Latin America Cancer Vaccine Market, by Vaccine Type
      • Preventive Cancer Vaccine
      • Therapeutic Cancer Vaccine
      • Others
    • Latin America Cancer Vaccine Market, by Indication Type
      • Prostate Cancer
      • Bladder Cancer
      • Melanoma
      • Cervical Cancer
      • Other
    • Latin America Cancer Vaccine Market, by Technology Type
      • Recombinant Cancer Vaccine
      • Whole-cell Cancer Vaccine
      • Viral Vector and DNA Cancer Vaccine
      • Other Technologies
    • Brazil
      • Brazil Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Brazil Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Brazil Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Argentina
      • Argentina Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Argentina Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Argentina Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
  • Middle East & Africa
    • Middle East & Africa Cancer Vaccine Market, by Vaccine Type
      • Preventive Cancer Vaccine
      • Therapeutic Cancer Vaccine
      • Others
    • Middle East & Africa Cancer Vaccine Market, by Indication Type
      • Prostate Cancer
      • Bladder Cancer
      • Melanoma
      • Cervical Cancer
      • Other
    • Middle East & Africa Cancer Vaccine Market, by Technology Type
      • Recombinant Cancer Vaccine
      • Whole-cell Cancer Vaccine
      • Viral Vector and DNA Cancer Vaccine
      • Other Technologies
    • South Africa
      • South Africa Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • South Africa Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • South Africa Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Saudi Arabia
      • Saudi Arabia Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Saudi Arabia Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Saudi Arabia Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • UAE
      • UAE Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • UAE Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • UAE Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies
    • Kuwait
      • Kuwait Cancer Vaccine Market, by Vaccine Type
        • Preventive Cancer Vaccine
        • Therapeutic Cancer Vaccine
        • Others
      • Kuwait Cancer Vaccine Market, by Indication Type
        • Prostate Cancer
        • Bladder Cancer
        • Melanoma
        • Cervical Cancer
        • Other
      • Kuwait Cancer Vaccine Market, by Technology Type
        • Recombinant Cancer Vaccine
        • Whole-cell Cancer Vaccine
        • Viral Vector and DNA Cancer Vaccine
        • Other Technologies

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2021 to 2033
• Market estimates and forecast for product segments up to 2033
• Regional market size and forecast for product segments up to 2033
• Market estimates and forecast for application segments up to 2033
• Regional market size and forecast for application segments up to 2033
• Company financial performance